Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About

Browse unicorn companies

Discover private companies that have reached unicorn status. 

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Altos LabsHealthcare
Biotech & Pharma
Low$xx.xx$xx.xx$xx.xxxx%--------Not available----$11.13BSeries C2/14/2024$1.5B$6.33B$25.02Undisclosed Investors
Colossal BiosciencesHealthcare
Biotech & Pharma
Medium$xx.xx$xx.xx$xx.xxxx%--------Not available----$620.64MSeries C2/3/2026$380M$10.32B$24.89TWG Global, Peter Jackson, US Innovative Technology Fund, Robert Nelsen, United Arab Emirates
Chai DiscoveryHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$620.17MSeries C7/14/2026$400M$3.8B$178.05Index Ventures, Kleiner Perkins, Sequoia Capital, Dimension, Bain Capital Ventures, Battery Ventures, Baillie Gifford, BDT & MSD, Sapphire Ventures, Avra Capital, Thrive Capital, OpenAI, Oak HC/FT, Menlo Ventures, General Catalyst, Glade Brook, Avenir, Lachy Groom, Yosemite, Scribble Ventures
Xaira TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1BSeries A4/23/2024$500M$2.65B$2.50ARCH Venture Partners, Foresite Capital, F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures, Parker Institute for Cancer Immunotherapy, Byers Capital, Rsquared, SV Angel, AIM13, Breyer Capital, Deviation Capital, Foresite Labs, JSL Health Capital, Longwood Fund, Sahsen Ventures, WRF Capital
InsitroHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--$1.36M--2Not available----$1.26BSeries C3/15/2021$400M$2.57B$18.29CPP Investments, Andreessen Horowitz, T. Rowe Price, Casdin Capital, BlackRock, ARCH Venture Partners, Foresite Capital, GV, Third Rock Ventures, Two Sigma Ventures, HOF Capital, Alexandria Venture Investments, Temasek, Softbank
Mammoth BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$379.07MSeries D-312/2/2025$15M$1.35B$13.45Undisclosed Investors
Kriya TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$940.5MSeries D9/10/2025$320.82M$1.67B$10.34Patient Square Capital, Premji Invest, Peter Thiel, Narya Capital, The T1D Fund
ArsenalBioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$2.44BSeries C9/4/2024$327.5M$1.66B$18.58ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures
Formation BioHealthcare
Biotech & Pharma
Low$xx.xx$xx.xx$xx.xxxx%--$294.00K--1Not available----$3.38BSeries D6/26/2024$372M$1.48B$8.18Andreessen Horowitz, Sanofi, Sequoia Capital, Thrive Capital, Emerson Collective, Lachy Groom, SV Angel Growth, FPV Ventures
Orca BioHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$541.19MSeries F1/9/2026$136.35M$2.4B$54.99Lightspeed Venture Partners
LetsGetCheckedHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
Twin HealthHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$366.48MSeries F6/29/2026$61.51M$1.4B$19.86Undisclosed Investors
OwkinHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$279.77MSeries B-16/8/2022$50M$1.46B$45.70Bristol Myers Squibb
Alloy TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$176.24MSeries E-14/15/2026$30M$1B$26.178VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, Ulysses Diversified Holdings
ResilienceHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$4.18BSeries D6/6/2022$625M$8.84B$60.73Undisclosed Investors
ImmunaiHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$295.22MSeries C-110/27/2021$204.34M$1.15B$186.65Koch Disruptive Technologies, Talos VC, 8VC, Alexanria Venture Investments, Piedmont, ICON
AlzheonHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$371.22MSeries E6/12/2024$100M$1.25B$62.71Alerce Medical Technology Partners
AsimovHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$241.8MSeries B1/5/2023$175M$1.24B$92.68CPP Investments, Fidelity, KDT, Casdin Capital, Pillar, Andreessen Horowitz, Horizons Ventures
Element BiosciencesHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$1.5BSeries D-17/11/2024$138.5M$1.05B$7.84Wellington Management, Samsung Electronics, Fidelity, Foresite Capital, T. Rowe Price Associates, Venrock
KallyopeHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$479.46MSeries D2/15/2022$236M$1.27B$5.45Mubadala, The Column Group, Alexandria Venture Investments, Bill Gates, Casdin Capital, Euclidean Capital, Illumina Ventures, Lux Capital, Polaris Partners, Two Sigma Ventures, StepStone Group, DNS Capital, Hartford Healthcare Endowment, Parkwood, Tao Capital
SynthegoHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$415.07MSeries E2/17/2022$144.17M$1.3B$10.78Perceptive Advisors, SoftBank, Declaration Partners, Laurion Capital Management, Logos Capital, GigaFund, Chimera Abu Dhabi, Wellington Management, RA Capital Management, Moore Strategic Ventures
Biosplice TherapeuticsHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available------Not available----------
MedableHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$530.96MSeries D10/26/2021$304.88M$2.1B$9.67Blackstone Growth, Tiger Global, GSR Ventures, Sapphire Ventures, WTI
BostonGeneHealthcare
Biotech & Pharma
Limited$xx.xx$xx.xx$xx.xxxx%--------Not available----$320MSeries B-212/4/2024$120M$1.46B$2.27Undisclosed Investors

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.